An announcement from Lexicon Pharmaceuticals (LXRX) is now available.
Lonnel Coats has announced his retirement as the CEO and board member of Lexicon Pharmaceuticals, effective from July 7, 2024. Following his departure, the company has begun the process of finding a successor, considering both internal and external candidates, to lead the organization into the future.
For an in-depth examination of LXRX stock, go to TipRanks’ Stock Analysis page.
